Regenaxis Therapeutics

Regenaxis Therapeutics is a preclinical-stage biotechnology company developing first-in-class therapies to regenerate myelin and restore function in demyelinating diseases of the central nervous system.

With a novel therapeutic approach targeting the biological mechanisms of remyelination, we aim to address a critical unmet need in neurology and unlock new therapeutic opportunities in neurodegeneration.